Turning Point Brands, Inc. (TPB) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2026. Turning Point Brands, Inc. is a leading manufacturer and distributor of branded consumer products, operating primarily through two segments: Zig-Zag products (rolling papers, cigars, accessories) and Stoker's products (moist snuff, loose-leaf tobacco, modern oral products). The company distributes products to approximately 220,000 retail outlets in North America.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $124.3 million | $106.4 million |
| Gross Profit | $68.3 million | $59.6 million |
| Gross Margin | 55.0% | 56.0% |
| Operating Income | $12.5 million | $23.2 million |
| Net Income (Attributable to TPB) | $11.7 million | $14.4 million |
| Diluted EPS | $0.60 | $0.79 |
| Cash and Cash Equivalents | $192.4 million | $222.8 million |
| Long-Term Debt | $293.9 million | $293.6 million |
| Operating Cash Flow | ($22.3 million) used | $17.4 million provided |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 16.8% year-over-year, driven by a 48.1% surge in the Stoker's segment (primarily modern oral products), which offset a 22.4% decline in the Zig-Zag segment.
- Profitability Decline: Despite revenue growth, operating income fell 46.2% to $12.5 million. This was primarily due to a 53.2% increase in Selling, General, and Administrative (SG&A) expenses, driven by higher shipping costs and marketing spend to support modern oral product growth.
- Cash Flow Shift: Operating cash flow turned negative ($22.3 million used) compared to positive cash flow in the prior year. This was caused by a $34.5 million unfavorable change in working capital, specifically a $21.7 million increase in inventory and a $19.2 million decrease in accrued liabilities.
- Tax Benefit: The effective tax rate was -25.2% (a benefit) compared to 11.4% expense in the prior year, largely due to the release of a $2.4 million valuation allowance on deferred tax assets.
Guidance, Outlook, and Risks
- Tariff Uncertainty: Following a U.S. Supreme Court ruling on IEEPA tariffs, the company has paid approximately $17.9 million in tariffs subject to potential refund. However, no asset has been recognized for these refunds due to administrative uncertainties.
- Regulatory Environment: The company faces ongoing risks related to FDA enforcement, potential flavor bans, and the Master Settlement Agreement (MSA). Costs related to FDA premarket tobacco product applications (PMTA) were $0.3 million in Q1 2026.
- Capital Allocation: The company maintains a $200.0 million share repurchase authorization (no repurchases in Q1 2026) and a $200.0 million At-The-Market (ATM) offering program. A quarterly dividend of $0.08 per share was paid in April 2026.
- Debt Structure: The company holds $300.0 million in 7.625% Senior Secured Notes due 2032 and has a $75.0 million asset-backed revolving credit facility (ABL) with $72.6 million available and no borrowings outstanding.
Investor Verification Checklist
- Inventory Build: Verify the rationale for the $21.7 million increase in inventory and its impact on future working capital needs.
- Tariff Refund Status: Monitor the administrative process for the $17.9 million in IEEPA tariff refunds and the likelihood of recovery.
- SG&A Efficiency: Assess whether the elevated SG&A expenses (up 53.2%) are sustainable or if they will compress margins as modern oral product growth stabilizes.
- Zig-Zag Segment Decline: Investigate the drivers behind the 22.4% sales decline in the core Zig-Zag segment and potential recovery strategies.
- Equity Method Income: Review the $3.0 million income from equity method investments (GWO) to understand its contribution to net income.